| 000 | 01804 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516175423.0 | ||
| 264 | 0 | _c20141027 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1742-7843 | ||
| 024 | 7 |
_a10.1111/bcpt.12166 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSherwin, Catherine M T | |
| 245 | 0 | 0 |
_aMaternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations. _h[electronic resource] |
| 260 |
_bBasic & clinical pharmacology & toxicology _cApr 2014 |
||
| 300 |
_a318-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 | _aLinear Models |
| 650 | 0 | 4 |
_aMagnesium Sulfate _xadministration & dosage |
| 650 | 0 | 4 | _aMaternal Exposure |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aPre-Eclampsia _xprevention & control |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Outcome |
| 650 | 0 | 4 |
_aPrenatal Exposure Delayed Effects _xblood |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTocolytic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aBalch, Alfred | |
| 700 | 1 | _aCampbell, Sarah C | |
| 700 | 1 | _aFredrickson, Jeunesse | |
| 700 | 1 | _aClark, Erin A S | |
| 700 | 1 | _aVarner, Michael | |
| 700 | 1 | _aStockmann, Chris | |
| 700 | 1 | _aKorgenski, E Kent | |
| 700 | 1 | _aBonkowsky, Joshua L | |
| 700 | 1 | _aSpigarelli, Michael G | |
| 773 | 0 |
_tBasic & clinical pharmacology & toxicology _gvol. 114 _gno. 4 _gp. 318-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcpt.12166 _zAvailable from publisher's website |
| 999 |
_c23206720 _d23206720 |
||